Buchholz U T, McNeil M M, Keyes L E, Good R C
Meningitis and Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
Clin Infect Dis. 1998 Sep;27(3):551-8. doi: 10.1086/514702.
Mycobacterium malmoense is a nontuberculous mycobacterium rarely encountered in the United States. However, isolations of M. malmoense from 73 patients (11 in 1992, 35 in 1993, and 27 in 1994) were reported to the Centers for Disease Control and Prevention. We contacted state mycobacteriology laboratories and health care providers of patients whose M. malmoense isolations were reported from January 1993 through June 1995. To assign disease status for these patients, we used the criteria of the American Thoracic Society. Of 60 evaluable patients with disease status, only six (10%) had disease due to M. malmoense (five adults with pulmonary disease and one child with cervical lymphadenitis). We conclude that the number of patients with disease due to M. malmoense remains low. Increased isolation of this species may be due to the increased use of more sensitive and specific laboratory methods. For surveillance purposes, multiple M. malmoense isolates and age of younger than 10 years appear to be the best predictors for M. malmoense disease.
马尔默分枝杆菌是一种在美国很少见的非结核分枝杆菌。然而,有73例马尔默分枝杆菌分离病例(1992年11例,1993年35例,1994年27例)报告给了疾病控制和预防中心。我们联系了1993年1月至1995年6月期间报告有马尔默分枝杆菌分离病例的患者所在州的分枝杆菌学实验室和医疗服务提供者。为了确定这些患者的疾病状况,我们采用了美国胸科学会的标准。在60例可评估疾病状况的患者中,仅有6例(10%)患有由马尔默分枝杆菌引起的疾病(5名患有肺部疾病的成年人和1名患有颈部淋巴结炎的儿童)。我们得出结论,由马尔默分枝杆菌引起疾病的患者数量仍然很少。该菌种分离率的增加可能是由于使用了更敏感和特异的实验室方法。出于监测目的,多个马尔默分枝杆菌分离株以及年龄小于10岁似乎是马尔默分枝杆菌疾病的最佳预测指标。